Stephen J Warner

Title: Innovations of Stephen J Warner in Guanylate Binding Proteins

Introduction

Stephen J Warner is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, particularly in the area of guanylate binding proteins. His work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Warner holds a patent for "Polynucleotides encoding novel guanylate binding proteins (GBP's)." This invention provides polynucleotides encoding human and murine guanylate binding protein polypeptides, fragments, and homologues thereof. The patent also includes vectors, host cells, antibodies, and methods for producing these polypeptides. Furthermore, it relates to diagnostic and therapeutic methods for applying guanylate binding protein polypeptides to the diagnosis, treatment, and prevention of diseases such as rheumatoid arthritis and conditions related to aberrant NF-κB activity, guanylate binding activity, and GTPase activity. The invention also encompasses screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides.

Career Highlights

Stephen J Warner is associated with Bristol-Myers Squibb Company, where he continues to contribute to innovative research and development. His work has been instrumental in advancing the understanding of guanylate binding proteins and their potential applications in medicine.

Collaborations

Warner has collaborated with notable colleagues, including Julie Carman and Rolf-Peter Ryseck. These collaborations have further enhanced the research and development efforts in the field of guanylate binding proteins.

Conclusion

Stephen J Warner's contributions to the field of biotechnology, particularly through his patent on guanylate binding proteins, highlight his role as an influential inventor. His work continues to pave the way for advancements in diagnostic and therapeutic methods.